Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Teleflex Incorporated Common Stock (NY:TFX)

132.78 -0.28 (-0.21%)
Official Closing Price Updated: 4:10 PM EDT, Oct 22, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Teleflex Incorporated Common Stock

< Previous 1 2 3 4 5 Next >
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
From Teleflex Incorporated
Via GlobeNewswire
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
The Trial Evaluates a Combined PCI Approach Using Drug-Coated Balloons and Drug-Eluting Stents 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business
From Teleflex Incorporated
Via GlobeNewswire
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Publishes 2024 Global Impact Report
Highlights Accomplishments and Sets Goals for Corporate Social Responsibility Program 
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting
From Teleflex Incorporated
Via GlobeNewswire
New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Announces Quarterly Dividend
From Teleflex Incorporated
Via GlobeNewswire
Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook
From Teleflex Incorporated
Via GlobeNewswire
TFX Investors Have Opportunity to Join Teleflex Incorporated Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Teleflex to Present at the BofA Securities 2025 Health Care Conference
From Teleflex Incorporated
Via GlobeNewswire
Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device
From Teleflex Incorporated
Via GlobeNewswire
Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation – TFX
From Rosen Law Firm
Via Business Wire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting
Experienced Urologists to Present Latest Findings and Host Multiple Educational Sessions 
From Teleflex Incorporated
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Teleflex Announces First Quarter 2025 Earnings Conference Call Information
From Teleflex Incorporated
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Teleflex Receives FDA 510(k) Clearance of the AC3 Range™ Intra-Aortic Balloon Pump (IABP)
The addition to the IABP family supports uncompromised cardiac support for patients during transport 
From Teleflex Incorporated
Via GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX
From Pomerantz LLP
Via GlobeNewswire
Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference
Prospective Multicenter Study Investigates Ringer™ PBC for Management of Coronary Perforations 
From Teleflex Incorporated
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.